Latest Insider Transactions at Eye Point Pharmaceuticals, Inc. (EYPT)
This section provides a real-time view of insider transactions for Eye Point Pharmaceuticals, Inc. (EYPT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of EyePoint Pharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of EyePoint Pharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 06
2026
|
George Elston Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,487
-4.66%
|
$71,792
$16.86 P/Share
|
|
Jan 06
2026
|
George Elston Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,285
+13.69%
|
-
|
|
Jan 06
2026
|
Jay S. Duker President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,054
-11.45%
|
$160,864
$16.86 P/Share
|
|
Jan 06
2026
|
Jay S. Duker President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,793
+19.15%
|
-
|
|
Jan 06
2026
|
Nancy Lurker |
BUY
Exercise of conversion of derivative security
|
Direct |
75,133
+20.33%
|
-
|
|
Jan 05
2026
|
Ramiro Ribeiro Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
42,544
-100.0%
|
$723,248
$17.1 P/Share
|
|
Jan 05
2026
|
Ramiro Ribeiro Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
29,250
+40.74%
|
$234,000
$8.26 P/Share
|
|
Jan 05
2026
|
George Elston Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,403
-5.15%
|
$74,851
$17.43 P/Share
|
|
Jan 05
2026
|
George Elston Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+14.93%
|
-
|
|
Jan 05
2026
|
Jay S. Duker President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
14,505
-17.79%
|
$246,585
$17.43 P/Share
|
|
Jan 05
2026
|
Jay S. Duker President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+26.9%
|
-
|
|
Jan 05
2026
|
Nancy Lurker |
BUY
Exercise of conversion of derivative security
|
Direct |
12,666
+5.46%
|
-
|
|
Jan 03
2026
|
Ramiro Ribeiro Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,373
-32.4%
|
$108,341
$17.48 P/Share
|
|
Jan 03
2026
|
Ramiro Ribeiro Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
19,667
+50.0%
|
-
|
|
Jan 03
2026
|
George Elston Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,324
-8.24%
|
$107,508
$17.48 P/Share
|
|
Jan 03
2026
|
George Elston Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
19,667
+20.39%
|
-
|
|
Jan 03
2026
|
Jay S. Duker President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
23,447
-31.28%
|
$398,599
$17.48 P/Share
|
|
Jan 03
2026
|
Jay S. Duker President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
65,000
+46.44%
|
-
|
|
Dec 19
2025
|
George Elston Chief Financial Officer |
BUY
Bona fide gift
|
Indirect |
5,000
+16.67%
|
-
|
|
Dec 19
2025
|
George Elston Chief Financial Officer |
SELL
Bona fide gift
|
Direct |
5,000
-8.05%
|
-
|
|
Dec 04
2025
|
Cormorant Asset Management, LP |
SELL
Open market or private sale
|
Indirect |
60,000
-0.72%
|
$900,000
$15.7 P/Share
|
|
Dec 04
2025
|
Nancy Lurker |
SELL
Open market or private sale
|
Direct |
9,300
-4.31%
|
$139,500
$15.11 P/Share
|
|
Nov 28
2025
|
Nancy Lurker |
SELL
Open market or private sale
|
Direct |
500
-0.23%
|
$7,000
$14.95 P/Share
|
|
Nov 26
2025
|
Nancy Lurker |
SELL
Open market or private sale
|
Direct |
200
-0.09%
|
$2,800
$14.95 P/Share
|
|
Nov 11
2025
|
Ramiro Ribeiro Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,722
-100.0%
|
$29,942
$11.61 P/Share
|
|
Sep 19
2025
|
George Elston Chief Financial Officer |
BUY
Bona fide gift
|
Indirect |
20,000
+50.0%
|
-
|
|
Sep 19
2025
|
George Elston Chief Financial Officer |
SELL
Bona fide gift
|
Direct |
20,000
-24.36%
|
-
|
|
Jul 11
2025
|
Karen L. Zaderej |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+4.94%
|
-
|
|
Jul 10
2025
|
Jay S. Duker President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,688
-43.55%
|
$84,568
$11.06 P/Share
|
|
Jul 10
2025
|
Jay S. Duker President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
16,667
+48.56%
|
-
|
|
Jul 10
2025
|
Nancy Lurker |
BUY
Exercise of conversion of derivative security
|
Direct |
11,111
+4.88%
|
-
|
|
Jun 23
2025
|
Jay S. Duker President and CEO |
SELL
Other acquisition or disposition
|
Direct |
56,665
-98.29%
|
$453,320
$8.21 P/Share
|
|
May 25
2025
|
George Elston Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,202
-2.65%
|
$11,010
$5.68 P/Share
|
|
May 25
2025
|
George Elston Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+8.28%
|
-
|
|
May 19
2025
|
Karen L. Zaderej |
BUY
Open market or private purchase
|
Direct |
5,000
+12.05%
|
$25,000
$5.99 P/Share
|
|
May 16
2025
|
Karen L. Zaderej |
BUY
Open market or private purchase
|
Direct |
5,000
+13.7%
|
$25,000
$5.81 P/Share
|
|
May 15
2025
|
Karen L. Zaderej |
BUY
Open market or private purchase
|
Direct |
5,000
+15.87%
|
$25,000
$5.47 P/Share
|
|
May 14
2025
|
Karen L. Zaderej |
BUY
Open market or private purchase
|
Direct |
5,000
+18.87%
|
$25,000
$5.42 P/Share
|
|
Mar 19
2025
|
Jay S. Duker President and CEO |
SELL
Other acquisition or disposition
|
Direct |
20,000
-25.76%
|
$120,000
$6.16 P/Share
|
|
Feb 09
2025
|
Jay S. Duker President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,055
-2.58%
|
$12,330
$6.5 P/Share
|
|
Feb 09
2025
|
Jay S. Duker President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+8.07%
|
-
|
|
Feb 09
2025
|
Nancy Lurker |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+8.87%
|
-
|
|
Feb 09
2025
|
George Elston Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,834
+7.17%
|
-
|
|
Jan 06
2025
|
Jay S. Duker President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,108
-7.75%
|
$48,864
$8.68 P/Share
|
|
Jan 06
2025
|
Jay S. Duker President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,794
+20.88%
|
-
|
|
Jan 06
2025
|
Nancy Lurker |
BUY
Exercise of conversion of derivative security
|
Direct |
75,134
+28.83%
|
-
|
|
Jan 06
2025
|
George Elston Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,808
-6.55%
|
$38,464
$8.68 P/Share
|
|
Jan 06
2025
|
George Elston Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,285
+17.24%
|
-
|
|
Jan 05
2025
|
Jay S. Duker President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,007
-14.71%
|
$80,056
$8.26 P/Share
|
|
Jan 05
2025
|
Jay S. Duker President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+30.6%
|
-
|